CD4 and type 2 diabetes mellitus: In contrast, the CAVEAT study found that NAbs and CD4 cytokine responses were lower in patients with T2DM with HbA1c levels > 7% than those with HbA1c levels ≤ 7%, implying that hyperglycemia at the time of vaccination might worsen the immunological response [48].